| Connolly Clinical Consultants Limited |
| Registered Number:08452865 |
For the year ended 31 March 2025
England and Wales
Unaudited Financial Statements
Connolly Clinical Consultants Limited
Statement of Financial Position and Notes to the Accounts
2024
2025
-
1,089
35,820
27,498
| Prepayments and accrued income |
3,484
-
| Creditors: amounts falling due |
(4,601)
(7,144)
22,897
32,160
Net current assets
| Total assets less current liabilities |
32,160
23,986
32,160
Net assets
23,986
32,160
23,986
Statutory Information
| Connolly Clinical Consultants Limited is a private limited company, limited by shares, domiciled in England and Wales, |
| registration number 08452865. |
20 Riverslea
Stokesley
Middlesbrough
Cleveland
TS9 5DE
| The presentation currency is £ sterling. |
| 1. Average number of persons employed |
During the year the average number of employees was 0
1 of 2
For the year ended 31 March 2025
Connolly Clinical Consultants Limited
Statement of Financial Position and Notes to the Accounts Continued
| For the year ended 31 March 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006. |
| The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
| each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
| 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
| statements, so far as applicable to the company. |
| These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
| These financial statements were approved and authorised for issue by the Board on 21 October 2025 and were signed by: |
2 of 2